- Home
- SOPH vs KOD Comparison
SOPH vs KOD Comparison
Compare SOPH & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPH
- KOD
- Stock Information
- Founded
- SOPH 2011
- KOD 2009
- Country
- SOPH Switzerland
- KOD United States
- Employees
- SOPH N/A
- KOD N/A
- Industry
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SOPH Health Care
- KOD Health Care
- Exchange
- SOPH Nasdaq
- KOD Nasdaq
- Market Cap
- SOPH 206.6M
- KOD 191.6M
- IPO Year
- SOPH 2021
- KOD 2018
- Fundamental
- Price
- SOPH $3.32
- KOD $2.81
- Analyst Decision
- SOPH Strong Buy
- KOD Hold
- Analyst Count
- SOPH 2
- KOD 4
- Target Price
- SOPH $6.50
- KOD $8.00
- AVG Volume (30 Days)
- SOPH 40.7K
- KOD 339.3K
- Earning Date
- SOPH 03-04-2025
- KOD 03-27-2025
- Dividend Yield
- SOPH N/A
- KOD N/A
- EPS Growth
- SOPH N/A
- KOD N/A
- EPS
- SOPH N/A
- KOD N/A
- Revenue
- SOPH $65,173,000.00
- KOD N/A
- Revenue This Year
- SOPH $16.63
- KOD N/A
- Revenue Next Year
- SOPH $26.11
- KOD N/A
- P/E Ratio
- SOPH N/A
- KOD N/A
- Revenue Growth
- SOPH 4.49
- KOD N/A
- 52 Week Low
- SOPH $2.70
- KOD $2.19
- 52 Week High
- SOPH $6.28
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- SOPH 48.85
- KOD 29.60
- Support Level
- SOPH $2.98
- KOD $2.97
- Resistance Level
- SOPH $3.75
- KOD $3.59
- Average True Range (ATR)
- SOPH 0.28
- KOD 0.27
- MACD
- SOPH 0.05
- KOD 0.04
- Stochastic Oscillator
- SOPH 44.08
- KOD 11.07
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.